Gsk (GSK) Consolidated Net Income (2009 - 2026)
Gsk (GSK) posted Consolidated Net Income of $2.91 billion for the quarter ended Sep 30, 2026, down 22.1% from $3.74 billion a year earlier.
Powered by 
Analysis
Gsk (GSK) Consolidated Net Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Consolidated Net Income at Gsk was $16.92 billion, up 65.8% year-over-year; for the year ended Dec 31, 2025, it came in at $8.29 billion, up 119.8% from the prior year.
- Annual Consolidated Net Income shows a five-year compound annual growth rate of 0.2% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Consolidated Net Income was $3.77 billion in the year ended Dec 31, 2024 (-42.9%), $6.6 billion in the year ended Dec 31, 2023 (-65.8%), $19.33 billion in the year ended Dec 31, 2022 (+175.7%) and $7.01 billion in the year ended Dec 31, 2021 (-14.5%).
- Quarterly Consolidated Net Income has run from a low of $81.86 million in the quarter ended Sep 30, 2024 to a high of $12.75 billion in the quarter ended Sep 30, 2022 over five years.
- On a year-over-year basis, Consolidated Net Income increased in four of the last seven quarters, with growth averaging 89.4%.
- The strongest year-over-year quarter for Consolidated Net Income in the past five years was the quarter ended Dec 31, 2025, with growth of 710.1%; the weakest was the quarter ended Sep 30, 2024, with a decline of 95.6%.
- According to Business Quant data, Consolidated Net Income for the three prior quarters was $207.96 million (quarter ended Jun 30, 2026), $2.48 billion (quarter ended Mar 31, 2026) and $11.32 billion (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.91 Bn |
| Jun 30, 2026 | 207.96 Mn |
| Mar 31, 2026 | 2.48 Bn |
| Dec 31, 2025 | 11.32 Bn |
| Sep 30, 2025 | 3.74 Bn |
| Jun 30, 2025 | 2.84 Bn |
| Mar 31, 2025 | 2.23 Bn |
| Dec 31, 2024 | 1.40 Bn |
| Sep 30, 2024 | 81.86 Mn |
| Jun 30, 2024 | 2.13 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 493.98 Mn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 2.18 Bn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 2.14 Bn |
| Sep 30, 2022 | 14.72 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 2.91 Bn |
| Dec 31, 2021 | 1.25 Bn |
API Access
Gsk Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();